BORTEZOMIB
NDC 70771-1708 · Zydus Lifesciences Limited
Generic nameBORTEZOMIB
Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
RouteINTRAVENOUS, SUBCUTANEOUS
Active ingredient(s)BORTEZOMIB
Strength1 mg/mL
Pharmacologic classProteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]
Marketing categoryANDA
Packages
70771-1708-1 — 1 VIAL, SINGLE-DOSE in 1 CARTON (70771-1708-1) / 3.5 mL in 1 VIAL, SINGLE-DOSE
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
63323-821 — Bortezomib, 63759-3032 — Bortezomib, 67184-0530 — Bortezomib, 68001-534 — Bortezomib, 68001-540 — Bortezomib, 68001-541 — Bortezomib, 68083-650 — Bortezomib, 68083-651 — Bortezomib, 70069-836 — bortezomib, 70121-2484 — Bortezomib, 70511-161 — bortezomib, 70511-162 — bortezomib, 70710-1411 — BORTEZOMIB, 71288-118 — Bortezomib, 72205-183 — Bortezomib, 72338-200 — bortezomib, 72603-270 — Bortezomib, 75007-501 — Bortezomib, 83090-008 — Bortezomib, 83634-208 — bortezomib, +11 more